Zealand Pharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Zealand Pharma and buy or sell other stocks, ETFs, and their options commission-free!

About ZEAL

Zealand Pharma A/S is a biotechnology company, which engages in the discovery, design, and development of peptide based medicines. Its products include Zegalogue and V-Go. 

CEO
Adam Sinding Steensberg, MD, MBA
CEOAdam Sinding Steensberg, MD, MBA
Employees
481
Employees481
Headquarters
Soborg, Zealand
HeadquartersSoborg, Zealand
Founded
1997
Founded1997
Employees
481
Employees481

ZEAL Key Statistics

Market cap
1.24B
Market cap1.24B
Price-Earnings ratio
-4.51
Price-Earnings ratio-4.51
Dividend yield
Dividend yield
Average volume
1.70K
Average volume1.70K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$32.94
52 Week high$32.94
52 Week low
$9.93
52 Week low$9.93

ZEAL News

TipRanks 24h
Zealand Pharma price target lowered to DKK 460 from DKK 1,000 at JPMorgan

JPMorgan lowered the firm’s price target on Zealand Pharma (ZLDPF) to DKK 460 from DKK 1,000 and keeps an Overweight rating on the shares. Published first on T...

TipRanks 6d
Zealand Pharma downgraded to Neutral from Outperform at BNP Paribas

BNP Paribas downgraded Zealand Pharma (ZLDPF) to Neutral from Outperform with a DKK 275 price target Published first on TheFly – the ultimate source for real-t...

MarketWatch 6d
Disappointing weight-loss-drug trial results from Zealand Pharma send shares tumbling

Zealand Pharma’s stock tumbled Friday as it sought to defend its experimental weight-loss drug after it fell short of Wall Street’s expectations. Shares of the...

Disappointing weight-loss-drug trial results from Zealand Pharma send shares tumbling

More ZEAL News

TipRanks 6d
Zealand Pharma downgraded to Market Perform from Outperform at William Blair

William Blair downgraded Zealand Pharma (ZLDPF) to Market Perform from Outperform without a price target The magnitude of weight loss disappointed in the Phase...

TipRanks 6d
Zealand Pharma downgraded to Hold from Buy at SEB Equities

SEB Equities downgraded Zealand Pharma (ZLDPF) to Hold from Buy with a DKK 380 price target Published first on TheFly – the ultimate source for real-time, mark...

The Wall Street Journal 6d
Roche, Zealand Pharma Obesity Drug Hits Goal in Midstage Trial

Roche Holding said an experimental obesity drug it is jointly developing with Zealand Pharma met its primary goal. Sedat Suna/Getty Images Roche Holding ROG -1...

Roche, Zealand Pharma Obesity Drug Hits Goal in Midstage Trial

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.